Roger M. Perlmutter
CIK: 0001184228
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EIKN
Eikon Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About PERLMUTTER ROGER M
PERLMUTTER ROGER M (SEC CIK 0001184228) files insider reports with the SEC as Director of Eikon Therapeutics, Inc. (EIKN).
Signal8 holds 3 ownership filings by PERLMUTTER ROGER M (1 Form 3, 2 Form 4), filed between Feb 4, 2026 and Mar 4, 2026. Those filings report 2 transactions, from Feb 6, 2026 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PERLMUTTER ROGER M's filings is in MILLBRAE, CA.
Recent filings by PERLMUTTER ROGER M
Other insiders filing for Eikon Therapeutics, Inc. (EIKN)
- Column Group IV GP, LP, 10% Owner
- Francisco Ma. Fatima, Director
- Klobuchar Michael A, Chief Operating Officer
- Huffines Robert Luther, Director
- FRAZIER KENNETH C, Director
- Thorner Benjamin Bruno